In consideration of the semaglutide-related GI AEs, treatment with GLP-1 RAs should begin with a structured dose-escalation schedule aimed at minimising these effects [64,65,66]
According to the Phase 3 trial involving around 2,500 patients, people taking the highest dose of Retatrutide lost an average of 28.3 per cent of their body weight, approximately 70 pounds, over 80 weeks
Who Should Avoid Taking Retatrutide Due to Side Effect Risks
Peptide Mind provides evidence-based research summaries and does not offer medical advice, diagnosis, or treatment recommendations
During my research I realized that there were very few, if any, medically directed programs focused towards achieving a Healthier Lifestyle rather than typical Diet fads. A few years later after training and working with some of the worlds foremost Bio-identical Hormone Replacement specialists I became Board Certified in Anti-Aging and Regenerative Medicine